{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:57:26Z","timestamp":1778813846910,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T00:00:00Z","timestamp":1584576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Amsterdam UMC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose of Review<\/jats:title><jats:p>To evaluate the impact of the implementation of the Rome IV criteria on pediatric gastrointestinal practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Recent Findings<\/jats:title><jats:p>In 2016, the Rome IV criteria were published, providing an update of symptom-based criteria to diagnose children with functional gastrointestinal disorders (FGIDs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary<\/jats:title><jats:p>For neonates and toddlers, Wessel\u2019s criteria for diagnosing infant colic were abandoned, and a differentiation was made between toilet-trained and non-toilet-trained children in the diagnosis of functional constipation. For children and adolescents, two new disorders (functional nausea and functional vomiting) are described, and in the diagnosis of functional dyspepsia, pain does not have to be the chief complaint anymore. This change has made functional dyspepsia the most common functional abdominal pain disorder, exceeding the prevalence of irritable bowel syndrome (IBS). Lastly, the diagnosis of abdominal migraine was narrowed, causing an appropriate drop in its prevalence.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s11894-020-00760-8","type":"journal-article","created":{"date-parts":[[2020,3,19]],"date-time":"2020-03-19T10:02:48Z","timestamp":1584612168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The Effects of the Rome IV Criteria on Pediatric Gastrointestinal Practice"],"prefix":"10.1007","volume":"22","author":[{"given":"Desiree F.","family":"Baaleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Benninga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Saps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,19]]},"reference":[{"key":"760_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpeds.2017.12.012","volume":"195","author":"SG Robin","year":"2018","unstructured":"\u2022 Robin SG, Keller C, Zwiener R, Hyman PE, Nurko S, Saps M, et al. Prevalence of pediatric functional gastrointestinal disorders utilizing the Rome IV criteria. J Pediatr. 2018;195:134\u20139 Study on the prevalence of functional gastrointestinal disorders in infants and toddlers, and children and adolescents.","journal-title":"J Pediatr"},{"key":"760_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jpeds.2018.03.037","volume":"199","author":"M Saps","year":"2018","unstructured":"\u2022 Saps M, Velasco-Benitez CA, Langshaw AH, Ram\u00edrez-Hern\u00e1ndez CR. Prevalence of functional gastrointestinal disorders in children and adolescents: comparison between Rome III and Rome IV criteria. J Pediatr. 2018;199:212\u20136 Study on the prevalence of functional gastrointestinal disorders in children and adolescents.","journal-title":"J Pediatr"},{"issue":"6","key":"760_CR3","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1053\/j.gastro.2016.02.016","volume":"150","author":"MA Benninga","year":"2016","unstructured":"\u2022\u2022 Benninga MA, Nurko S, Faure C, Hyman PE, Roberts ISJ, Schechter NL. Childhood functional gastrointestinal disorders: neonate\/toddler. Gastroenterology. 2016;150(6):1443\u201355. e2 The Rome IV criteria for neonates\/toddlers.","journal-title":"Gastroenterology"},{"issue":"6","key":"760_CR4","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1053\/j.gastro.2016.02.015","volume":"150","author":"JS Hyams","year":"2016","unstructured":"\u2022\u2022 Hyams JS, Di Lorenzo C, Saps M, Shulman RJ, Staiano A, van Tilburg M. Childhood functional gastrointestinal disorders: child\/adolescent. Gastroenterology. 2016;150(6):1456\u201368. e2 The Rome IV criteria for children\/adolescents.","journal-title":"Gastroenterology"},{"issue":"5","key":"760_CR5","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1053\/j.gastro.2005.08.063","volume":"130","author":"A Rasquin","year":"2006","unstructured":"Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, et al. Childhood functional gastrointestinal disorders: child\/adolescent. Gastroenterology. 2006;130(5):1527\u201337.","journal-title":"Gastroenterology."},{"issue":"5","key":"760_CR6","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1053\/j.gastro.2005.11.065","volume":"130","author":"PE Hyman","year":"2006","unstructured":"Hyman PE, Milla PJ, Benninga MA, Davidson GP, Fleisher DF, Taminiau J. Childhood functional gastrointestinal disorders: neonate\/toddler. Gastroenterology. 2006;130(5):1519\u201326.","journal-title":"Gastroenterology."},{"key":"760_CR7","doi-asserted-by":"publisher","first-page":"Ii60","DOI":"10.1136\/gut.45.2008.ii60","volume":"45 Suppl 2","author":"A Rasquin-Weber","year":"1999","unstructured":"Rasquin-Weber A, Hyman PE, Cucchiara S, Fleisher DR, Hyams JS, Milla PJ, et al. Childhood functional gastrointestinal disorders. Gut. 1999;45 Suppl 2:Ii60\u20138. https:\/\/doi.org\/10.1136\/gut.45.2008.ii60.","journal-title":"Gut"},{"issue":"5","key":"760_CR8","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1053\/j.gastro.2006.03.008","volume":"130","author":"DA Drossman","year":"2006","unstructured":"Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377\u201390.","journal-title":"Gastroenterology"},{"issue":"5","key":"760_CR9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1542\/peds.14.5.421","volume":"14","author":"MA Wessel","year":"1954","unstructured":"Wessel MA, Cobb JC, Jackson EB, Harris GS, Detwiler AC. Paroxysmal fussing in infancy, sometimes called \u201ccolic\u201d. Pediatrics. 1954;14(5):421\u201335.","journal-title":"Pediatrics."},{"issue":"3","key":"760_CR10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/apa.13270","volume":"105","author":"Y Vandenplas","year":"2016","unstructured":"Vandenplas Y, Benninga M, Broekaert I, Falconer J, Gottrand F, Guarino A, et al. Functional gastro-intestinal disorder algorithms focus on early recognition, parental reassurance and nutritional strategies. Acta Paediatr. 2016;105(3):244\u201352. https:\/\/doi.org\/10.1111\/apa.13270.","journal-title":"Acta Paediatr"},{"issue":"8","key":"760_CR11","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41575-018-0008-7","volume":"15","author":"J Zeevenhooven","year":"2018","unstructured":"Zeevenhooven J, Browne PD, L\u2019Hoir MP, de Weerth C, Benninga MA. Infant colic: mechanisms and management. Nat Rev Gastroenterol Hepatol. 2018;15(8):479\u201396. https:\/\/doi.org\/10.1038\/s41575-018-0008-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"760_CR12","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/j.cgh.2015.05.014","volume":"13","author":"RS Choung","year":"2015","unstructured":"Choung RS, Rubio-Tapia A, Lahr BD, Kyle RA, Camilleri MJ, Locke GR, et al. Evidence against routine testing of patients with functional gastrointestinal disorders for celiac disease: a population-based study. Clin Gastroenterol Hepatol. 2015;13(11):1937\u201343. https:\/\/doi.org\/10.1016\/j.cgh.2015.05.014.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"760_CR13","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/mpg.0000000000001479","volume":"65","author":"KL Watson Jr","year":"2017","unstructured":"Watson KL Jr, Kim SC, Boyle BM, Saps M. Prevalence and impact of functional abdominal pain disorders in children with inflammatory bowel diseases (IBD-FAPD). J Pediatr Gastroenterol Nutr. 2017;65(2):212\u20137. https:\/\/doi.org\/10.1097\/mpg.0000000000001479.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"760_CR14","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/archdischild-2012-302906","volume":"98","author":"JM Rutten","year":"2013","unstructured":"Rutten JM, Reitsma JB, Vlieger AM, Benninga MA. Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review. Arch Dis Child. 2013;98(4):252\u20137. https:\/\/doi.org\/10.1136\/archdischild-2012-302906.","journal-title":"Arch Dis Child"},{"issue":"3","key":"760_CR15","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/MPG.0b013e318173ed39","volume":"47","author":"BU Li","year":"2008","unstructured":"Li BU, Lefevre F, Chelimsky GG, Boles RG, Nelson SP, Lewis DW, et al. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr. 2008;47(3):379\u201393. https:\/\/doi.org\/10.1097\/MPG.0b013e318173ed39.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"760_CR16","doi-asserted-by":"publisher","unstructured":"The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629\u2013808. doi:https:\/\/doi.org\/10.1177\/0333102413485658.","DOI":"10.1177\/0333102413485658"},{"key":"760_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13052-014-0092-4","volume":"40","author":"D Spiri","year":"2014","unstructured":"Spiri D, Rinaldi VE, Titomanlio L. Pediatric migraine and episodic syndromes that may be associated with migraine. Ital J Pediatr. 2014;40:92. https:\/\/doi.org\/10.1186\/s13052-014-0092-4.","journal-title":"Ital J Pediatr"},{"issue":"3","key":"760_CR18","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/MPG.0b013e3182964203","volume":"57","author":"K Kovacic","year":"2013","unstructured":"Kovacic K, Williams S, Li BUK, Chelimsky G, Miranda A. High prevalence of nausea in children with pain-associated functional gastrointestinal disorders: are Rome criteria applicable? J Pediatr Gastroenterol Nutr. 2013;57(3):311\u20135. https:\/\/doi.org\/10.1097\/MPG.0b013e3182964203.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"760_CR19","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/mpg.0000000000001076","volume":"62","author":"K Kovacic","year":"2016","unstructured":"Kovacic K, Di Lorenzo C. Functional nausea in children. J Pediatr Gastroenterol Nutr. 2016;62(3):365\u201371. https:\/\/doi.org\/10.1097\/mpg.0000000000001076.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"760_CR20","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cgh.2016.07.006","volume":"15","author":"AC Russell","year":"2017","unstructured":"Russell AC, Stone AL, Walker LS. Nausea in children with functional abdominal pain predicts poor health outcomes in young adulthood. Clin Gastroenterol Hepatol. 2017;15(5):706\u201311. https:\/\/doi.org\/10.1016\/j.cgh.2016.07.006.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"20","key":"760_CR21","doi-asserted-by":"publisher","first-page":"6013","DOI":"10.3748\/wjg.v20.i20.6013","volume":"20","author":"BK Sandhu","year":"2014","unstructured":"Sandhu BK, Paul SP. Irritable bowel syndrome in children: pathogenesis, diagnosis and evidence-based treatment. World J Gastroenterol. 2014;20(20):6013\u201323. https:\/\/doi.org\/10.3748\/wjg.v20.i20.6013.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"760_CR22","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/17512433.2018.1540298","volume":"11","author":"PD Browne","year":"2018","unstructured":"Browne PD, Nagelkerke SCJ, van Etten-Jamaludin FS, Benninga MA, Tabbers MM. Pharmacological treatments for functional nausea and functional dyspepsia in children: a systematic review. Expert Rev Clin Pharmacol. 2018;11(12):1195\u2013208. https:\/\/doi.org\/10.1080\/17512433.2018.1540298.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"5","key":"760_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/j.1365-2354.2006.00736.x","volume":"16","author":"J RICHARDSON","year":"2007","unstructured":"RICHARDSON J, SMITH JE, MCCALL G, RICHARDSON A, PILKINGTON K, KIRSCH I. Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. Eur J Cancer Care. 2007;16(5):402\u201312. https:\/\/doi.org\/10.1111\/j.1365-2354.2006.00736.x.","journal-title":"Eur J Cancer Care"},{"issue":"5","key":"760_CR24","doi-asserted-by":"publisher","first-page":"e0126982","DOI":"10.1371\/journal.pone.0126982","volume":"10","author":"JJ Korterink","year":"2015","unstructured":"Korterink JJ, Diederen K, Benninga MA, Tabbers MM. Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis. PLoS One. 2015;10(5):e0126982\u2013e. https:\/\/doi.org\/10.1371\/journal.pone.0126982.","journal-title":"PLoS One"},{"issue":"4","key":"760_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S2468-1253(18)30003-7","volume":"3","author":"I Aziz","year":"2018","unstructured":"Aziz I, Palsson OS, T\u00f6rnblom H, Sperber AD, Whitehead WE, Simr\u00e9n M. Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study. Lancet Gastroenterol Hepatol. 2018;3(4):252\u201362. https:\/\/doi.org\/10.1016\/S2468-1253(18)30003-7.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"760_CR26","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jpeds.2012.12.096","volume":"163","author":"L Rodriguez","year":"2013","unstructured":"Rodriguez L, Diaz J, Nurko S. Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children. J Pediatr. 2013;163(1):261\u20137. https:\/\/doi.org\/10.1016\/j.jpeds.2012.12.096.","journal-title":"J Pediatr"},{"issue":"3","key":"760_CR27","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/mpg.0000000000000964","volume":"62","author":"S Madani","year":"2016","unstructured":"Madani S, Cortes O, Thomas R. Cyproheptadine use in children with functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2016;62(3):409\u201313. https:\/\/doi.org\/10.1097\/mpg.0000000000000964.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"760_CR28","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.cgh.2012.06.036","volume":"10","author":"J Tack","year":"2012","unstructured":"Tack J, Janssen P, Masaoka T, Farr\u00e9 R, Van Oudenhove L. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 2012;10(11):1239\u201345. https:\/\/doi.org\/10.1016\/j.cgh.2012.06.036.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"760_CR29","unstructured":"US Food and Drug Administration. FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs: agency warns against chronic use of these products to treat gastrointestinal disorders. Silver Spring, MD: FDA. 2009. https:\/\/wayback.archive-it.org\/7993\/20170112033201\/http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2009\/ucm149533.htm."},{"issue":"3","key":"760_CR30","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4212\/cjhp.v69i3.1560","volume":"69","author":"AD Morris","year":"2016","unstructured":"Morris AD, Chen J, Lau E, Poh J. Domperidone-associated QT interval prolongation in non-oncologic pediatric patients: a review of the literature. Canadian J Hosp Pharm. 2016;69(3):224\u201330. https:\/\/doi.org\/10.4212\/cjhp.v69i3.1560.","journal-title":"Canadian J Hosp Pharm"},{"issue":"7","key":"760_CR31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/nmo.12104","volume":"25","author":"PL Lu","year":"2013","unstructured":"Lu PL, Teich S, Lorenzo CD, Skaggs B, Alhajj M, Mousa HM. Improvement of quality of life and symptoms after gastric electrical stimulation in children with functional dyspepsia. Neurogastroenterol Motil. 2013;25(7):567\u2013e456. https:\/\/doi.org\/10.1111\/nmo.12104.","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"760_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jpedsurg.2012.10.038","volume":"48","author":"S Teich","year":"2013","unstructured":"Teich S, Mousa HM, Punati J, Di Lorenzo C. Efficacy of permanent gastric electrical stimulation for the treatment of gastroparesis and functional dyspepsia in children and adolescents. J Pediatr Surg. 2013;48(1):178\u201383. https:\/\/doi.org\/10.1016\/j.jpedsurg.2012.10.038.","journal-title":"J Pediatr Surg"},{"issue":"3","key":"760_CR33","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/MPG.0b013e31816c4372","volume":"47","author":"KF Baber","year":"2008","unstructured":"Baber KF, Anderson J, Puzanovova M, Walker LS. Rome II versus Rome III classification of functional gastrointestinal disorders in pediatric chronic abdominal pain. J Pediatr Gastroenterol Nutr. 2008;47(3):299\u2013302.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"760_CR34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/nmo.12056","volume":"25","author":"MAL van Tilburg","year":"2013","unstructured":"van Tilburg MAL, Squires M, Blois-Martin N, Leiby A, Langseder A. Test of the child\/adolescent Rome III criteria: agreement with physician diagnosis and daily symptoms. Neurogastroenterol Motil. 2013;25(4):302\u2013e246. https:\/\/doi.org\/10.1111\/nmo.12056.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"760_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/MPG.0b013e31818de3ab","volume":"49","author":"H Helgeland","year":"2009","unstructured":"Helgeland H, Flagstad G, Gr\u00f8tta J, Vandvik PO, Kristensen H, Markestad T. Diagnosing pediatric functional abdominal pain in children (4\u201315 years old) according to the Rome III criteria: results from a Norwegian prospective study. J Pediatr Gastroenterol Nutr. 2009;49(3):309\u201315.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"760_CR36","first-page":"S","volume":"146","author":"M Saps","year":"2014","unstructured":"Saps M, Sztainberg M, Pusatcioglu C, Chogle A. Tu2007 Accuracy of diagnosis for abdominal migraine in children. Gastroenterology. 2014;146(5):S\u2013897.","journal-title":"Gastroenterology"},{"key":"760_CR37","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2147\/PHMT.S127210","volume":"9","author":"J Mani","year":"2018","unstructured":"Mani J, Madani S. Pediatric abdominal migraine: current perspectives on a lesser known entity. Pediatric Health Med Ther. 2018;9:47\u201358. https:\/\/doi.org\/10.2147\/PHMT.S127210.","journal-title":"Pediatric Health Med Ther"},{"issue":"1","key":"760_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/adc.72.1.48","volume":"72","author":"DN Symon","year":"1995","unstructured":"Symon DN, Russell G. Double blind placebo controlled trial of pizotifen syrup in the treatment of abdominal migraine. Arch Dis Child. 1995;72(1):48\u201350. https:\/\/doi.org\/10.1136\/adc.72.1.48.","journal-title":"Arch Dis Child"},{"issue":"5","key":"760_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jpeds.2007.10.012","volume":"152","author":"RJ Bahar","year":"2008","unstructured":"Bahar RJ, Collins BS, Steinmetz B, Ament ME. Double-blind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008;152(5):685\u20139. https:\/\/doi.org\/10.1016\/j.jpeds.2007.10.012.","journal-title":"J Pediatr"},{"issue":"6","key":"760_CR40","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1053\/j.gastro.2016.03.035","volume":"150","author":"DA Drossman","year":"2016","unstructured":"Drossman DA, Hasler WL. Rome IV\u2014functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150(6):1257\u201361.","journal-title":"Gastroenterology."},{"issue":"5","key":"760_CR41","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jpeds.2013.12.043","volume":"164","author":"E Giannetti","year":"2014","unstructured":"Giannetti E, de\u2019Angelis G, Turco R, Campanozzi A, Pensabene L, Salvatore S, et al. Subtypes of irritable bowel syndrome in children: prevalence at diagnosis and at follow-up. J Pediatr. 2014;164(5):1099\u2013103.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2013.12.043.","journal-title":"J Pediatr"},{"issue":"9","key":"760_CR42","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1016\/j.cgh.2014.01.031","volume":"12","author":"MM Self","year":"2014","unstructured":"Self MM, Czyzewski DI, Chumpitazi BP, Weidler EM, Shulman RJ. Subtypes of irritable bowel syndrome in children and adolescents. Clin Gastroenterol Hepatol. 2014;12(9):1468\u201373. https:\/\/doi.org\/10.1016\/j.cgh.2014.01.031.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"760_CR43","doi-asserted-by":"publisher","first-page":"CD010972-CD","DOI":"10.1002\/14651858.CD010972.pub2","volume":"3","author":"TV Newlove-Delgado","year":"2017","unstructured":"Newlove-Delgado TV, Martin AE, Abbott RA, Bethel A, Thompson-Coon J, Whear R, et al. Dietary interventions for recurrent abdominal pain in childhood. Cochrane Database Syst Rev. 2017;3(3):CD010972-CD. https:\/\/doi.org\/10.1002\/14651858.CD010972.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"760_CR44","unstructured":"IV R. Interactive Clinical Decision Toolkit. 2016 http:\/\/theromefoundation.org\/rome-iv-interactive-clinical-decision-toolkit\/. Accessed 12\/5\/2019."},{"issue":"11","key":"760_CR45","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/ajg.2012.254","volume":"107","author":"WD Chey","year":"2012","unstructured":"Chey WD, Lembo AJ, Lavins BJ, Shiff SJ, Kurtz CB, Currie MG, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol. 2012;107(11):1702\u201312. https:\/\/doi.org\/10.1038\/ajg.2012.254.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"760_CR46","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2036.2009.04081.x","volume":"30","author":"L Wedlake","year":"2009","unstructured":"Wedlake L, A\u2019Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009;30(7):707\u201317. https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04081.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"760_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12325-019-01116-z","volume":"37","author":"DM Brenner","year":"2019","unstructured":"Brenner DM, Sayuk GS. Current US Food and Drug Administration-approved pharmacologic therapies for the treatment of irritable bowel syndrome with diarrhea. Adv Ther. 2019;37:83\u201396. https:\/\/doi.org\/10.1007\/s12325-019-01116-z.","journal-title":"Adv Ther"},{"key":"760_CR48","doi-asserted-by":"publisher","unstructured":"Jativa-Marino E, Rivera-Valenzuela MG, Velasco-Benitez CA, Saps M. The prevalence of functional constipation in children was unchanged after the Rome IV criteria halved the diagnosis period in Rome III. Acta Paediatr. 2019. https:\/\/doi.org\/10.1111\/apa.14880.","DOI":"10.1111\/apa.14880"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-020-00760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-020-00760-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-020-00760-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T05:26:22Z","timestamp":1666157182000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-020-00760-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,19]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["760"],"URL":"https:\/\/doi.org\/10.1007\/s11894-020-00760-8","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,19]]},"assertion":[{"value":"19 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Miguel Saps has served as a Scientific Consultant for Allergan, Ironwood, and Forest. Marc A. Benninga has served as a Scientific Consultant for Allergan, Norgine, Coloplast, Danone, FrieslandCampina, Sensus, and Takeda. These companies have had no input or involvement in any aspect of this study. The other authors have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All reported studies\/experiments with human or animal subjects performed by the authors have been previously published, unless stated otherwise, and complied with all applicable ethical standards (including the Helsinki declaration and its amendments, institutional\/national research committee standards, and international\/national\/institutional guidelines).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}],"article-number":"21"}}